|
T40997 |
GLP-1R modulator C16
|
GLP-1R modulator C16 |
Glucagon Receptor
|
|
GLP-1R modulator C16 is a variable modulator that significantly increases the binding affinity of GLP-4. |
|
T40279 |
GLP-1R modulator L7-028
|
GLP-1R modulator L7-028 |
cAMP
,
Glucagon Receptor
|
|
GLP-1R modulator L7-028 is a variant modulator that enhances affinity for GLP-1 and cAMP signaling. |
|
T11409 |
GLP-26
|
|
HBV
|
|
GLP-26 disrupts the encapsidation of pre-genomic RNA, causes nucleocapsid disassembly and reduces cccDNA pools. GLP-26 is a HBV capsid assembly modulators (CAM), inhibits HBV DNA replication in Hep AD38 system (IC50=3 nM... |
|
T3984 |
GLP-1(7-36), amide
|
MKC 253,Human GLP-1-(7-36)-amide,Glucagon-like Peptide 1 (7-36) amide,Glucagon-Like Peptide (GLP) I (7-36), amide, human,GLP-1(7-36),GLP-1-(7-36)-amide |
Glucagon Receptor
|
|
GLP-1(7-36), amide (MKC 253) is a peptide hormone released from intestinal L-cells upon nutrient consumption. It binds the GLP-1 receptor in the pancreas and displays various antidiabetic effects by potentiating glucose-... |
|
T37890L |
GLP-1(28-36)amide acetate
|
GLP-1(28-36)amide acetate(1225021-13-5 Free base) |
Antioxidant
,
Glucagon Receptor
|
|
GLP-1(28-36)amide acetate inhibits mitochondrial permeability transition with antioxidant, anti-diabetic and cardioprotection activities. |
|
TP1376 |
GLP-1(7-37) acetate(106612-94-6 free base)
|
GLP-1(7-37) acetate |
Others
,
Glucagon Receptor
|
|
Glp-1(7-37) acetate is an intestinal insulin hormone that enhances glucose-induced insulin secretion. |
|
T9579L |
GLP-1 receptor agonist 9 citrate
|
GLP-1 receptor agonist 9 citrate (2401892-71-3 Free base) |
Glucagon Receptor
|
|
GLP-1 receptor agonist 9 citrate is an agonist of GLP-1. |
|
T37891L |
GLP-1(32-36)amide acetate
|
GLP-1(32-36)amide acetate(1417302-71-6 Free base) |
Others
|
|
GLP-1(32-36)amide acetate is a pentapeptide and derived from the C terminus of the glucoregulatory hormone GLP-1. GLP-1(32-36)amide acetate could inhibit weight gain and modulate whole body glucose metabolism in diabetic... |
|
T15387 |
GLP-1R Antagonist 1
|
|
Glucagon Receptor
|
|
GLP-1R Antagonist 1 is an orally active, CNS penetrant and non-competitive glucagon-like peptide 1 receptor (GLP-1R) antagonist (IC50: 650 nM). |
|
TP2252 |
GLP-1 (9-36) amide
|
|
Glucagon Receptor
|
|
antagonist at the human GLP-1 receptor |
|
T36579 |
GLP-1R Agonist DMB
|
|
Glucagon Receptor
|
|
GLP-1R Agonist DMB is an agonist of glucagon-like peptide 1 receptor (GLP-1R; KB = 26.3 nM for the recombinant human receptor). |
|
T9579 |
GLP-1 receptor agonist 9
|
|
Glucagon Receptor
|
|
1H-Benzimidazole-6-carboxylic acid is a GLP-1 receptor agonist. |
|
T63909 |
GLP-1R agonist 3
|
|
Glucagon Receptor
|
|
GLP-1R agonist 3 is a thickened imidazole derivative compound that is a potent agonist of GLP-1R. GLP-1R agonist 3 has shown research potential in diabetes. |
|
T61483 |
GLP-1R modulator C5
|
|
Glucagon Receptor
|
|
GLP-1R modulator C5 is a small molecule GLP-1R orthosteric modulator that enhances GLP-1 binding to GLP-1R via transmembrane sites and can be used in the study of type II diabetes. |
|
TP2253 |
GLP-2(rat)
|
GLP-2 (rat) |
Others
|
|
intestinal epithelium-specific growth factor |
|
T11408 |
Orforglipron
|
LY3502970,GLP-1 receptor agonist 1 |
Glucagon Receptor
|
|
Orforglipron (LY3502970; GLP-1 receptor agonist 1) is an orally available glucagon-like peptide (GLP-1) receptor agonist for the study of obesity and type 1 diabetes in adults. |
|
TP1141 |
GLP-1(7-36), amide acetate
|
GLP-1(7-36) Acetate,Human GLP-1-(7-36)-amide Acetate |
|
|
GLP-1(7-36) Acetate is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells. |
|
TP1157 |
GLP-2(1-33)(human)
|
GLP-2 (human),Glucagon-like peptide 2 (human) |
|
|
GLP-2(1-33) (human) is an enteroendocrine hormone which stimulates the growth of the intestinal epithelium. |
|
T37891 |
GLP-1(32-36)amide
|
|
|
|
GLP-1(32-36)amide is a pentapeptide compound derived from the C terminus of the glucoregulatory hormone GLP-1. This compound has shown potential in inhibiting weight gain and regulating glucose metabolism in diabetic mic... |
|
T37890 |
GLP-1(28-36)amide
|
|
|
|
GLP-1(28-36)amide, a C-terminal nonapeptide derived from the cleavage of GLP-1 by neutral endopeptidase (NEP), is a significant product. It functions as an antioxidant and primarily targets the mitochondrion, where it ef... |
|
TP1306 |
GLP-1(7-37)
|
|
|
|
GLP-1 (7-37) is a truncated, bioactive form of GLP-1 that is the product of proglucagon processing in intestinal endocrine L cells. |
|
T37892 |
GLP-1(7-36), amide TFA
|
|
|
|
GLP-1(7-36), amide TFA is a prominent intestinal hormone known to stimulate glucose-induced insulin secretion from β cells[1]. |
|
TP1316 |
GLP-1 moiety from Dulaglutide
|
|
|
|
GLP-1 moiety from Dulaglutide is a 31-amino acid fragment of Dulaglutide which is a glucagon-like peptide 1 receptor (GLP-1) agonist. |
|
TP1487 |
Glucagon-Like Peptide (GLP) II, human
|
|
|
|
Glucagon-like peptide 2 (GLP-2) is a recently identified intestinal epithelium-specific growth factor that has been shown to reduce the severity of inflammatory disorders of the intestine in rodent models. Currently Gluc... |
|
T11407 |
GLP-1 receptor agonist 2
|
|
Others
|
|
GLP-1 receptor agonist 2 is a glucagon-like peptide-1 receptor (GLP-1R) agonist. |
|
T11404 |
GLP-1 receptor agonist 3
|
|
Others
|
|
GLP-1 receptor agonist 3 is a GLP-1 receptor agonist,Example 4A-1, has EC50s of 1.1 nM and 13 nM in Clone H6 and Clone C6 cell lines assay, respectively. |
|
T11405 |
GLP-1 receptor agonist 4
|
|
Others
|
|
GLP-1 receptor agonist 4 is a glucagon-like peptide-1 receptor (GLP-1R) agonist , has an EC50 of 64.5 nM. GLP-1 receptor agonist 4 can be used in the research for treatment of diabetes. |
|
T36380 |
GLP-1 (1-36) amide (human, rat) (trifluoroacetate salt)
|
|
|
|
GLP-1 amide is a peptide hormone cleaved from proglucagon in the pancreas.1,2 Mice lacking the glucagon receptor (Gcgr-/-) have approximately nine-fold higher levels of total GLP-1 amide, including GLP-1 (1-36) amide and... |
|
T78571 |
Albiglutide fragment TFA
|
GLP-1-Gly8 TFA,GLP-1 (7-36) analog TFA |
|
|
Albiglutide fragment (GLP-1 (7-36) analog) TFA represents a biologically active segment of Albiglutide, resistant to DPP-4 degradation due to its structure as a GLP-1 analog. It functions as a long-acting agonist of the ... |
|
T74609 |
GLP-1R agonist 15
|
|
|
|
GLP-1R agonist 15 (Compound 101) is a GLP-1 receptor agonist [1] . |
|
T64180 |
GLP-1R agonist 1
|
|
|
|
GLP-1R agonist 1 is a thickened imidazole derivative compound and a potent agonist of GLP-1R. GLP-1R agonist 1 has potential for the study of diabetes. |
|
T74323 |
GLP-1R agonist 4
|
|
|
|
GLP-1R agonist 4, a potent agonist of GLP-1R, shows promise for diabetes research[1]. Acting on the principle of glucagon-like peptide-1 (GLP-1), a hypoglycemic hormone secreted by L-cells in the lower gastrointestinal t... |
|
T64007 |
GLP-1R agonist 10
|
|
|
|
GLP-1R agonist 10 is a GLP-1 agonist (EC50: 0.051 nM). |
|
T74610 |
GLP-1R agonist 16
|
|
|
|
Compound 115a, a GLP-1R agonist, effectively activates the GLP-1 receptor with an EC50 of 0.15 nM [1]. |
|
T64191 |
GLP-1R agonist 12
|
|
|
|
GLP-1R agonist 12 (Compound 123) is a GLP-1R agonist that can be used in the study of diabetes mellitus. |
|
T72686 |
GLP-1R agonist 9
|
|
|
|
GLP-1R agonist 9 acts as a GLP-1R agonist, demonstrating efficacy with EC50 values of 1.1 nM and 11 nM against CHO GLP-1R Clone H6 and Clone C6, respectively. |
|
T74608 |
GLP-1R agonist 14
|
|
|
|
GLP-1R agonist 14, also known as Compound 14, is a potent agonist of the GLP-1 receptor, demonstrating an EC50 range of 0-20 nM against human GLP-1 [1]. |
|
T63999 |
GLP-1R agonist 8
|
|
|
|
GLP-1R agonist 8 is a potent agonist of GLP-1R (EC50 < 2 nM). |
|
T72611 |
GLP-1R agonist 17
|
|
|
|
GLP-1R agonist 17 is a potent GLP-1 receptor agonist that demonstrates excellent efficacy in activating a GLP-1 receptor. It is primarily utilized in the research of cardiovascular metabolic diseases. |
|
T75823 |
GLP-2(rat) TFA
|
|
|
|
GLP-2(rat) TFA, an intestinal growth factor, promotes cell proliferation and prevents apoptosis. Additionally, it increases mucosal mass and function in the residual small intestine following massive small bowel resectio... |
|
T74132 |
GLP-1 receptor agonist 8
|
|
|
|
GLP-1 receptor agonist 8, a potent agonist of GLP-1 R, holds potential for diabetes, obesity, and nonalcoholic fatty liver disease (NAFLD) research[1]. |
|
T82308 |
GLP-2 (1-34) (human)
|
|
|
|
GLP-2 (1-34) (human), a polypeptide secreted from the intestine shortly after eating, is utilized in research related to bone remodeling processes [1]. |
|
T82307 |
Glp-His-Pro-Gly-NH2
|
pGlu-His-Pro-Gly-NH2 |
|
|
pGlu-His-Pro-Gly-NH2, also known as Glp-His-Pro-Gly-NH2, is a tetrapeptide that promotes the release of gonadotropin, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) [1] [2]. |
|
T79348 |
GLP-1 receptor agonist 13
|
|
|
|
Compound (S)-9, a GLP-1 receptor agonist, exhibits an EC50 of 76 nM for the glucagon GLP-1 receptor [1]. |
|
T64195 |
GLP-1 receptor agonist 7
|
|
|
|
GLP-1 receptor agonist 7 is a potent glucagon-like peptide-1 (GLP-1) agonist and has shown research potential for GLP-1 related diseases, disorders and conditions, including diabetes. |
|
T75822 |
GLP-1(9-36)amide TFA
|
|
|
|
GLP-1(9-36)amide TFA, a predominant metabolite of glucagon-like peptide-1-(7-36)amide synthesized through dipeptidyl peptidase-4 (DPP-4) activity, functions as an antagonist to the human pancreatic GLP-1 receptor [1] [2]... |
|
T76192 |
GLP-1(32-36)amide TFA
|
|
|
|
GLP-1(32-36)amide TFA, originating from the C-terminal end of the glucoregulatory hormone GLP-1, is a pentapeptide that has demonstrated the ability to mitigate weight gain and regulate glucose metabolism throughout the ... |
|
T76191 |
GLP-1(28-36)amide TFA
|
|
|
|
GLP-1(28-36)amide TFA, a C-terminal nonapeptide derived from GLP-1 cleavage by neutral endopeptidase (NEP), acts as an antioxidant targeting mitochondria. It inhibits mitochondrial permeability transition (MPT), exhibiti... |
|
T64553 |
GLP-1(7-37) TFA salt
|
|
|
|
The truncated glucagon-like peptides GLP-1(7-37) is naturally occurring peptide product of the preproglucagon gene that are synthesized primarily in the intestine and acts as incretin that are released from the intestine... |
|
T80453 |
GLP-1 (1-36) amide (human, rat)
|
Glucagon-like Peptide 1 (1-36) amide (human, rat) |
|
|
GLP-1 (1-36) amide (human, rat) is a molecular variant of the GLP-1 (7-36) amide and has the capacity to stimulate [14C]aminopyrine accumulation in enzymatically dispersed, enriched rat parietal cells [1]. |
